Syros Pharmaceuticals, Inc.
COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY

Last updated:

Abstract:

The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angiogenesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

30 Nov 2020

Issue date:

22 Jul 2021